Idorsia Ltd (IDIA) - Cash Flow Conversion Efficiency

Latest as of September 2025: 0.018x

Based on the latest financial reports, Idorsia Ltd (IDIA) has a cash flow conversion efficiency ratio of 0.018x as of September 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (CHF-20.73 Million ≈ $-26.21 Million USD) by net assets (CHF-1.14 Billion ≈ $-1.44 Billion USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.

Idorsia Ltd - Cash Flow Conversion Efficiency Trend (2016–2024)

This chart illustrates how Idorsia Ltd's cash flow conversion efficiency has evolved over time, based on yearly financial data. Read Idorsia Ltd balance sheet liabilities for a breakdown of total debt and financial obligations.

Idorsia Ltd Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Idorsia Ltd ranked by their cash flow conversion efficiency.

Company	Cash Flow Conversion Efficiency
Shanghai Amarsoft Information & Technolgy Co Ltd SHE:300380	-0.059x
indie Semiconductor Inc NASDAQ:INDI	-0.016x
Suzhou Alton Electrical & Mechanical Industry Co. Ltd. SHE:301187	-0.068x
Sky Gold Limited NSE:SKYGOLD	0.003x
Zehnder SW:ZEHN	0.213x
Hefei Fengle Seed Co Ltd SHE:000713	0.122x
EZTEC Empreendimentos e Participações S.A SA:EZTC3	0.042x
Contec Medical Systems Co Ltd SHE:300869	0.003x

Annual Cash Flow Conversion Efficiency for Idorsia Ltd (2016–2024)

The table below shows the annual cash flow conversion efficiency of Idorsia Ltd from 2016 to 2024. For the full company profile with market capitalisation and key ratios, see market cap of Idorsia Ltd.

Year	Net Assets	Operating Cash Flow	Cash Flow Conversion Efficiency	Change
2024-12-31	CHF-1.21 Billion ≈ $-1.53 Billion	CHF-370.23 Million ≈ $-468.07 Million	0.305x	-52.98%
2023-12-31	CHF-968.72 Million ≈ $-1.22 Billion	CHF-629.30 Million ≈ $-795.60 Million	0.650x	-50.02%
2022-12-31	CHF-660.96 Million ≈ $-835.63 Million	CHF-859.11 Million ≈ $-1.09 Billion	1.300x	+122.96%
2021-12-31	CHF104.20 Million ≈ $131.74 Million	CHF-589.89 Million ≈ $-745.79 Million	-5.661x	-808.88%
2020-12-31	CHF585.48 Million ≈ $740.21 Million	CHF-364.67 Million ≈ $-461.04 Million	-0.623x	+77.85%
2019-12-31	CHF164.35 Million ≈ $207.78 Million	CHF-462.04 Million ≈ $-584.14 Million	-2.811x	-424.02%
2018-12-31	CHF657.62 Million ≈ $831.42 Million	CHF-352.82 Million ≈ $-446.06 Million	-0.537x	-515.46%
2017-12-31	CHF739.51 Million ≈ $934.94 Million	CHF95.50 Million ≈ $120.73 Million	0.129x	+124.91%
2016-12-31	CHF507.97 Million ≈ $642.21 Million	CHF-263.34 Million ≈ $-332.93 Million	-0.518x	--

About Idorsia Ltd

SW:IDIA Switzerland Biotechnology

Market Cap

$1.14 Billion

CHF905.23 Million CHF

Market Cap Rank

#10420 Global

#126 in Switzerland

Share Price

CHF3.68

Change (1 day)

+1.60%

52-Week Range

CHF1.28 - CHF4.70

All Time High

CHF33.62